HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Keating Selected Research

acivicin (AT 125)

7/2001High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Keating Research Topics

Disease

12B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 03/2000
11Neoplasms (Cancer)
01/2018 - 01/2000
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2007 - 02/2000
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2007 - 09/2000
5Leukemia
01/2018 - 02/2000
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2007 - 01/2000
3Lymphoma (Lymphomas)
01/2018 - 06/2000
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2002 - 12/2000
2Hematologic Neoplasms (Hematological Malignancy)
03/2007 - 04/2001
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
09/2000 - 02/2000
1Pleural Effusion (Pleural Effusions)
07/2017
1Chromosome Aberrations (Chromosome Abnormalities)
09/2002
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2002
1Lymphocytosis
12/2001
1Anemia
10/2001
1Cytopenia
10/2001
1Pure Red-Cell Aplasia
10/2001
1Thrombocytopenia (Thrombopenia)
10/2001
1Wounds and Injuries (Trauma)
08/2001
1Burns
08/2001
1Hepatomegaly
07/2001
1Splenomegaly
07/2001
1Mucositis
07/2001
1Philadelphia Chromosome
04/2001
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2001
1Neoplasm Metastasis (Metastasis)
04/2001
1Infections
03/2001
1Pneumonia (Pneumonitis)
03/2001
1Sepsis (Septicemia)
03/2001
1Neutropenia
03/2001
1Prolymphocytic Leukemia
12/2000
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2000
1Necrosis
09/2000
1Ataxia Telangiectasia (Louis Bar Syndrome)
03/2000
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2000

Drug/Important Bio-Agent (IBA)

3Hemoglobins (Hemoglobin)IBA
07/2017 - 07/2001
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2001 - 07/2000
2Proteins (Proteins, Gene)FDA Link
06/2007 - 07/2001
2Cyclin D1IBA
09/2002 - 06/2000
2fludarabineIBA
10/2001 - 03/2001
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2001 - 09/2000
2Cytarabine (Cytosar-U)FDA LinkGeneric
07/2001 - 02/2000
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
04/2001 - 09/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2001 - 02/2000
1Interleukin-15 (Interleukin 15)IBA
01/2018
1ibrutinibIBA
01/2018
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2018
1Chimeric Antigen ReceptorsIBA
01/2018
1Syndecan-1 (Syndecan 1)IBA
02/2009
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
06/2007
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2007
1DNA (Deoxyribonucleic Acid)IBA
01/2003
1N 30IBA
12/2001
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2001
1EnzymesIBA
08/2001
1TransCyteIBA
08/2001
1angiogeninIBA
08/2001
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2001
1Daunorubicin (Cerubidine)FDA LinkGeneric
07/2001
1Glycoproteins (Glycoprotein)IBA
07/2001
1acivicin (AT 125)IBA
07/2001
1Interferon-alpha (Interferon Alfa)IBA
04/2001
1Rituximab (Mabthera)FDA Link
12/2000
1Monoclonal AntibodiesIBA
12/2000
1CD20 AntigensIBA
12/2000
1Transforming Growth Factor alpha (TGF-alpha)IBA
09/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2000
1Ataxia Telangiectasia Mutated ProteinsIBA
03/2000
1Topoisomerase I InhibitorsIBA
02/2000
1Topotecan (Hycamtin)FDA LinkGeneric
02/2000
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2000

Therapy/Procedure

7Therapeutics
03/2007 - 10/2000
2Combination Drug Therapy (Combination Chemotherapy)
04/2001 - 03/2001
1Immunomodulation
01/2018
1Ligation
11/2010
1Artificial Skin
08/2001
1Length of Stay
08/2001